Effect of intrauterine growth retardation on the progression of nephrotic syndrome

Yo Won Na, Hae Joung Yang, Jeong Hoon Choi, Kee Hwan Yoo, Young Sook Hong, Joo Won Lee, Soon Kyum Kim

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background/Aim: Neonates with intrauterine growth retardation (IUGR) experience higher morbidity and mortality rates than appropriate-for-gestational-age (AGA) neonates. The purpose of our study was to clarify whether IUGR has any influences on the progression of nephrotic syndrome in children. Methods: We performed a retrospective review of 56 children with nephrotic syndrome. IUGR was defined as a birth weight less than the tenth percentile for gestational age. Among 56 patients having nephrotic syndrome, 8 had IUGR, and 48 were AGA. Results: The 24-hour urinary protein level in children with IUGR was significantly higher than that in children who were AGA (7.61 ± 6.75 vs. 3.92 ± 3.70 g/day, p < 0.05). There was a statistically significant difference in the incidence of steroid resistance (62.5 vs. 10.4%, p < 0.05) and in the time to remission (median 60 vs. 13 days, p < 0.05) between the children with IUGR and those being AGA. Also, there was a significant difference in the incidences of treatment with cytotoxic agents (75 vs. 29.2%, p < 0.05) and complications such as hypertension. Conclusions: Our report indicates that IUGR predicts an unfavorable progression of nephrotic syndrome. So, it is important for nephrologists to pay attention to the clinical course of nephrotic syndrome in neonates with IUGR.

Original languageEnglish
Pages (from-to)463-467
Number of pages5
JournalAmerican Journal of Nephrology
Volume22
Issue number5-6
DOIs
Publication statusPublished - 2002 Dec 1

Fingerprint

Fetal Growth Retardation
Nephrotic Syndrome
Gestational Age
Newborn Infant
Incidence
Cytotoxins
Birth Weight
Steroids
Hypertension
Morbidity
Mortality

Keywords

  • Cytotoxic agents
  • Hypertension
  • Intrauterine growth retardation
  • Nephrotic syndrome
  • Steroid resistance

ASJC Scopus subject areas

  • Nephrology

Cite this

Na, Y. W., Yang, H. J., Choi, J. H., Yoo, K. H., Hong, Y. S., Lee, J. W., & Kim, S. K. (2002). Effect of intrauterine growth retardation on the progression of nephrotic syndrome. American Journal of Nephrology, 22(5-6), 463-467. https://doi.org/10.1159/000065275

Effect of intrauterine growth retardation on the progression of nephrotic syndrome. / Na, Yo Won; Yang, Hae Joung; Choi, Jeong Hoon; Yoo, Kee Hwan; Hong, Young Sook; Lee, Joo Won; Kim, Soon Kyum.

In: American Journal of Nephrology, Vol. 22, No. 5-6, 01.12.2002, p. 463-467.

Research output: Contribution to journalArticle

Na, Yo Won ; Yang, Hae Joung ; Choi, Jeong Hoon ; Yoo, Kee Hwan ; Hong, Young Sook ; Lee, Joo Won ; Kim, Soon Kyum. / Effect of intrauterine growth retardation on the progression of nephrotic syndrome. In: American Journal of Nephrology. 2002 ; Vol. 22, No. 5-6. pp. 463-467.
@article{bb65aa692a8143348d67c93aaef935fe,
title = "Effect of intrauterine growth retardation on the progression of nephrotic syndrome",
abstract = "Background/Aim: Neonates with intrauterine growth retardation (IUGR) experience higher morbidity and mortality rates than appropriate-for-gestational-age (AGA) neonates. The purpose of our study was to clarify whether IUGR has any influences on the progression of nephrotic syndrome in children. Methods: We performed a retrospective review of 56 children with nephrotic syndrome. IUGR was defined as a birth weight less than the tenth percentile for gestational age. Among 56 patients having nephrotic syndrome, 8 had IUGR, and 48 were AGA. Results: The 24-hour urinary protein level in children with IUGR was significantly higher than that in children who were AGA (7.61 ± 6.75 vs. 3.92 ± 3.70 g/day, p < 0.05). There was a statistically significant difference in the incidence of steroid resistance (62.5 vs. 10.4{\%}, p < 0.05) and in the time to remission (median 60 vs. 13 days, p < 0.05) between the children with IUGR and those being AGA. Also, there was a significant difference in the incidences of treatment with cytotoxic agents (75 vs. 29.2{\%}, p < 0.05) and complications such as hypertension. Conclusions: Our report indicates that IUGR predicts an unfavorable progression of nephrotic syndrome. So, it is important for nephrologists to pay attention to the clinical course of nephrotic syndrome in neonates with IUGR.",
keywords = "Cytotoxic agents, Hypertension, Intrauterine growth retardation, Nephrotic syndrome, Steroid resistance",
author = "Na, {Yo Won} and Yang, {Hae Joung} and Choi, {Jeong Hoon} and Yoo, {Kee Hwan} and Hong, {Young Sook} and Lee, {Joo Won} and Kim, {Soon Kyum}",
year = "2002",
month = "12",
day = "1",
doi = "10.1159/000065275",
language = "English",
volume = "22",
pages = "463--467",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Effect of intrauterine growth retardation on the progression of nephrotic syndrome

AU - Na, Yo Won

AU - Yang, Hae Joung

AU - Choi, Jeong Hoon

AU - Yoo, Kee Hwan

AU - Hong, Young Sook

AU - Lee, Joo Won

AU - Kim, Soon Kyum

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Background/Aim: Neonates with intrauterine growth retardation (IUGR) experience higher morbidity and mortality rates than appropriate-for-gestational-age (AGA) neonates. The purpose of our study was to clarify whether IUGR has any influences on the progression of nephrotic syndrome in children. Methods: We performed a retrospective review of 56 children with nephrotic syndrome. IUGR was defined as a birth weight less than the tenth percentile for gestational age. Among 56 patients having nephrotic syndrome, 8 had IUGR, and 48 were AGA. Results: The 24-hour urinary protein level in children with IUGR was significantly higher than that in children who were AGA (7.61 ± 6.75 vs. 3.92 ± 3.70 g/day, p < 0.05). There was a statistically significant difference in the incidence of steroid resistance (62.5 vs. 10.4%, p < 0.05) and in the time to remission (median 60 vs. 13 days, p < 0.05) between the children with IUGR and those being AGA. Also, there was a significant difference in the incidences of treatment with cytotoxic agents (75 vs. 29.2%, p < 0.05) and complications such as hypertension. Conclusions: Our report indicates that IUGR predicts an unfavorable progression of nephrotic syndrome. So, it is important for nephrologists to pay attention to the clinical course of nephrotic syndrome in neonates with IUGR.

AB - Background/Aim: Neonates with intrauterine growth retardation (IUGR) experience higher morbidity and mortality rates than appropriate-for-gestational-age (AGA) neonates. The purpose of our study was to clarify whether IUGR has any influences on the progression of nephrotic syndrome in children. Methods: We performed a retrospective review of 56 children with nephrotic syndrome. IUGR was defined as a birth weight less than the tenth percentile for gestational age. Among 56 patients having nephrotic syndrome, 8 had IUGR, and 48 were AGA. Results: The 24-hour urinary protein level in children with IUGR was significantly higher than that in children who were AGA (7.61 ± 6.75 vs. 3.92 ± 3.70 g/day, p < 0.05). There was a statistically significant difference in the incidence of steroid resistance (62.5 vs. 10.4%, p < 0.05) and in the time to remission (median 60 vs. 13 days, p < 0.05) between the children with IUGR and those being AGA. Also, there was a significant difference in the incidences of treatment with cytotoxic agents (75 vs. 29.2%, p < 0.05) and complications such as hypertension. Conclusions: Our report indicates that IUGR predicts an unfavorable progression of nephrotic syndrome. So, it is important for nephrologists to pay attention to the clinical course of nephrotic syndrome in neonates with IUGR.

KW - Cytotoxic agents

KW - Hypertension

KW - Intrauterine growth retardation

KW - Nephrotic syndrome

KW - Steroid resistance

UR - http://www.scopus.com/inward/record.url?scp=0036974782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036974782&partnerID=8YFLogxK

U2 - 10.1159/000065275

DO - 10.1159/000065275

M3 - Article

VL - 22

SP - 463

EP - 467

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 5-6

ER -